Ò½ÉúµÇ¼
ÆóÒµ/Ò©³§µÇ¼
ÇëÊäÈëÄúµÄÒ½ÉúÕ˺ŵǼ
Óû§Ãû£º
ÃÜ  Â룺
 ¼ÇסÃÜÂë    
 ×¢²á»áÔ±     ÕÒ»ØÃÜÂë
ÇëÊäÈëÄúµÄÆóÒµ/Ò©³§Õ˺ŵǼ
Óû§Ãû£º
ÃÜ  Â룺
 ¼ÇסÃÜÂë    
 ×¢²á»áÔ±     ÕÒ»ØÃÜÂë
¸÷´óÖÞ¹ú¼Ò£º
»áÕ¹¿ÆÊÒ£º
»áչʱ¼ä£º
¹Ø¼ü×ÖËÑË÷£º
北美洲
Äúµ±Ç°µÄλÖÃ:Ê×Ò³ > Õ¹»á¼Æ»® > 北美洲
2011Ä꺺Ãܶû¶ÙӲƤ²¡¸üлáÒ飨HSU£©
»áÕ¹Ãû³Æ  2011Ä꺺Ãܶû¶ÙӲƤ²¡¸üлáÒ飨HSU£©
²¼Õ¹Ê±¼ä  2011Äê9ÔÂ23ÈÕ
Õ¹ÀÀʱ¼ä  2011Äê9ÔÂ24ÈÕ
³·Õ¹Ê±¼ä  2011Äê9ÔÂ25ÈÕ
ËùÔÚµØÖ·

 ¼ÓÄôó ¹þÃܶû¶Ù

»áÕ¹³¡¹Ý  ¹þÃܶû¶Ù»áÒéÖÐÐÄ
²Î»á×¢²á·Ñ  ¿ÉÒÔ. »áÔ±/·Ç»áÔ±  ·þÎñ·Ñ300ÈËÃñ±Ò/ÈË
´úËÍÇ©Ö¤  ¿ÉÒÔ. ·þÎñ·Ñ500ÈËÃñ±Ò/ÈË
´ú¶©»úƱ  ¿ÉÒÔ. ÇëÓë¿Í·þÈËÔ±ÁªÏµ
´ú¶¨Õ¹Î»

 ²»¿ÉÒÔ

´ú¶¨¾Æµê

 ¿ÉÒÔ. ·þÎñ·ÑΪ×Ü·ÑÓÃ15%

»áÕ¹ÃèÊö

 The event has been designed as a one day learning experience for both scleroderma patients and healthcare professionals. It will feature current evidence and best practice information regarding early diagnosis, ongoing disease monitoring and recognition of important medical warning signs, treatment options and management strategies to provide guidance for patients and healthcare professionals. The goal is that better management of scleroderma as a multi-spectrum, chronic disease will be achieved.

ʼþÒѱ»Éè¼Æ³ÉÓÐÒ»ÌìµÄѧϰ¾­ÑéΪӲƤ²¡»¼ÕߺÍÒ½»¤ÈËÔ±¡£Ëü½«¹¦ÄÜ£¬ÏÖÓеÄÖ¤¾ÝºÍ×î¼Ñʵ¼ùÐÅÏ¢£¬¶ÔÔçÆÚÕï¶Ï£¬³ÖÐøµÄ¼²²¡¼à²âºÍÖØÒªµÄÒ½Áƾ¯¸æ±êÖ¾£¬ÖÎÁÆ·½°¸ºÍ¹ÜÀí²ßÂÔµÄÈÏͬ£¬Îª²¡È˺ÍÒ½»¤ÈËÔ±µÄÖ¸µ¼¡£ÎÒÃǵÄÄ¿±êÊǸüºÃµØ¹ÜÀí×÷Ϊһ¸ö¶à¹âÆ×£¬Ó²Æ¤²¡£¬ÂýÐÔ¼²²¡½«µÃÒÔʵÏÖ¡£

Õ¹»áÖÜÆÚ

 Ã¿ÄêÒ»½ì¡¡

×¢ÒâÊÂÏî

 1.ÒÔÉϱê×¢"¿ÉÒÔ"µÄ·þÎñÏîÄ¿¿Éµ¥¶À°ìÀí.
 2.µ¥Ïî·þÎñµÄ·ÑÓÃÒÔ×îÖÕÈ·Èϵ¥Îª×¼.
 3.²Î»áÕûÌåÁ÷³Ì·þÎñ·Ñ1000ÈËÃñ±Ò/ÈË.
   ·þÎñ·Ñ°üº¬:´úËÍÇ©Ö¤¡¢´ú¶©Íù·µ»úƱ¡¢´ú¶©µ±µØ¾Æµê.  
   ·þÎñ·Ñ²»º¬:¸÷ÏîÄ¿Ëù²úÉúµÄʵ¼Ê·ÑÓÃ.

ÔÚÏß×Éѯ

 ÈçÄúÓÐÆäËûÐèÇó»ò½¨ÒéÇëµã»÷ÕâÀï.

ÓÑÇéÌáʾ

 »ãÂʼÆËãÒÔ¸¶¿îʱÖйú¹¤ÉÌÒøÐÐÍâ»ãÂô³ö¼ÛΪ׼.

ÁªÏµ·½Ê½

 ×Éѯµç»°: 8610-66054455  8610-51294800   ÉèËߵ绰: 8610-66054488
 ÔÚÏß¿Í·þ: MSN:fanmeiguojikefu@hotmail.com    QQ:1391456367

ÓÑÇéÁ´½Ó£º 
| ÁªÏµµç»°£º010-66054488 | ÔÚÏß¿Í·þ£ºQQ 1391456367 | µØÖ·£º±±¾©Êж«³ÇÇø½ðÓã³ØÖнÖ2ºÅÔº4-2-506 |
°æȨËùÓÐ È«Çòҽѧ»áÕ¹ All rights Reserved. ICPÖ¤£º¾©ICP±¸10011105ºÅ-2